Cargando…
Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor
Chemoresistant cancer cells express high levels of aldehyde dehydrogenases (ALDHs), particularly in head and neck squamous cell carcinoma (HNSCC). The ALDH family of enzymes detoxify both exogenous and endogenous aldehydes. Since many chemotherapeutic agents, such as cisplatin, result in the generat...
Autores principales: | Kim, Jeewon, Shin, June Ho, Chen, Che-Hong, Cruz, Leslie, Farnebo, Lovisa, Yang, Jieying, Borges, Paula, Kang, Gugene, Mochly-Rosen, Daria, Sunwoo, John B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581033/ https://www.ncbi.nlm.nih.gov/pubmed/28881734 http://dx.doi.org/10.18632/oncotarget.17017 |
Ejemplares similares
-
Aldehyde dehydrogenase 2*2 knock-in mice show increased reactive oxygen species production in response to cisplatin treatment
por: Kim, Jeewon, et al.
Publicado: (2017) -
Mitochondrial aldehyde dehydrogenase and cardiac diseases
por: Chen, Che-Hong, et al.
Publicado: (2010) -
Aldehyde dehydrogenase 2 activation and coevolution of its εPKC-mediated phosphorylation sites
por: Nene, Aishwarya, et al.
Publicado: (2017) -
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma
por: Farnebo, Lovisa, et al.
Publicado: (2015) -
Development of Selective Inhibitors
for Aldehyde Dehydrogenases
Based on Substituted Indole-2,3-diones
por: Kimble-Hill, Ann C., et al.
Publicado: (2014)